A Phase 2, Multicenter, Randomized, Double-Blind, Placebo Controlled Study of the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Gabapentin Extended Release (G-ER) Tablets in the Treatment of Vasomotor Symptoms in Postmenopausal Women.

Trial Profile

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo Controlled Study of the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Gabapentin Extended Release (G-ER) Tablets in the Treatment of Vasomotor Symptoms in Postmenopausal Women.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Sep 2012

At a glance

  • Drugs Gabapentin (Primary)
  • Indications Hot flashes; Menopausal syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 May 2009 Results presented at ACOG 2009.
    • 26 Sep 2008 Results have been presented in a poster at the 2008 NAMS, according to a Depomed media release.
    • 13 Feb 2008 Positive efficacy results have been reported in a Depomed media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top